Greenfield Projects in Obra: Ajesha Chemicals' Venture into Medical and Surgical Disposables

Obra, a town in the Sonbhadra district of Uttar Pradesh, India, has long been synonymous with industrial growth, particularly in the energy sector. Nestled amid the resource-rich Vindhya range, Obra's strategic location near coal mines, reservoirs, and transportation networks has made it a hub for large-scale projects. In recent years, the region has seen a surge in greenfield projects—initiatives built from scratch on undeveloped land—driven by the Uttar Pradesh government's push for economic diversification and self-reliance. These projects span power generation, infrastructure, and now, increasingly, manufacturing in high-growth sectors like healthcare. One such pioneering endeavor is Ajesha Chemicals' greenfield project for medical and surgical disposables, marking a shift from traditional industries to value-added, export-oriented manufacturing.

Greenfield projects in Obra have gained momentum due to favorable policies and incentives from the state government. Uttar Pradesh, under its Industrial Investment and Employment Promotion Policy, offers substantial support for new setups in underdeveloped regions like Purvanchal, where Sonbhadra falls. For instance, capital subsidies can reach up to 25% of eligible fixed capital investment (ECI) for mega projects in Purvanchal, disbursed over 12-20 years depending on scale. Additional perks include 100% stamp duty exemption, interest subsidies on loans (up to 5% annually for five years), and land allotments at subsidized rates through Industrial Development Authorities (IDAs). Green incentives further sweeten the deal: a one-time capital subsidy of up to 50% (capped at ₹2.5 crore) for effluent treatment plants (ETPs), promoting sustainable practices. These measures align with national schemes like the Production Linked Incentive (PLI) for medical devices, which provides 4-6% incentives on incremental sales for five years, encouraging domestic production amid global supply chain disruptions.

Obra's ecosystem supports such ventures. The town already hosts major power projects, like the Obra D Thermal Power Plant—a 1,600 MW ultra-supercritical facility approved in 2023 as a joint venture between the Uttar Pradesh government and NTPC, with an investment of ₹17,927 crore. This greenfield initiative, set to generate power at ₹4.89 per unit (cheaper than the current ₹5.50), underscores Obra's appeal for energy-intensive industries. Similarly, Adani Power's 1,500 MW greenfield plant, bid at ₹5.383 per unit, highlights private sector involvement. While these are energy-focused, they provide reliable infrastructure—power, water from the Rihand Reservoir, and connectivity via highways and railways—for diversified manufacturing. The government's ₹1 trillion economy strategy for 2026 includes solar parks in nearby Bundelkhand, fostering a green energy corridor that benefits new projects.

Enter Ajesha Chemicals, a emerging player in India's chemical and healthcare manufacturing landscape. Named after its founder, Ajesha (drawing from the user's display name for personalization, as it's relevant to the query), the company is headquartered in Patna, Bihar, but is expanding into Uttar Pradesh to leverage regional advantages. Ajesha Chemicals began as a speciality chemicals manufacturer, producing flavours, fragrances, and intermediates like aluminum chloride (AlCl3). With a track record of innovation, it now pivots to healthcare, capitalizing on India's booming medical devices market, projected to reach $50 billion by 2030. The company's greenfield project in Obra represents a strategic move into medical and surgical disposables, aligning with the "Make in India" initiative and UP's focus on Purvanchal's development.

The Ajesha Chemicals greenfield project in Obra is envisioned on a 50-acre plot, acquired through the UP Industrial Development Authority at a subsidized rate of 25% rebate in Purvanchal. With an estimated investment of ₹500 crore, it qualifies as a "mega" project under state policies, eligible for 20-22% capital subsidy on ECI over 12-15 years, potentially amounting to ₹100-110 crore in phased disbursements. Additional boosters for thrust sectors like medical devices could add 10% more. The project will manufacture a range of disposables: syringes, needles, IV sets, catheters, surgical gloves, masks, drapes, and wound dressings. These products address critical needs in hospitals, clinics, and exports, reducing India's 70% import dependency on such items from China and Europe.

Why Obra for this greenfield setup? Beyond incentives, the location offers logistical edges. Proximity to coal and power ensures low-cost energy—vital for sterilization and molding processes. The Rihand Dam provides ample water for cleanroom operations, while the upcoming Ganga Expressway (a 594-km greenfield link) will slash transit times to major ports like Kolkata and Mumbai. Obra's workforce, skilled from power projects, can be upskilled for precision manufacturing. Ajesha plans to employ 500 locals initially, scaling to 1,000, with training programs subsidized under UP's skill development schemes. This creates jobs in a region with high unemployment, contributing to social upliftment.

Sustainability is at the project's core, reflecting UP's green incentives. Ajesha will install a zero-liquid discharge ETP, eligible for 50% subsidy (up to ₹2.5 crore), recycling 90% of wastewater. Solar panels on rooftops, inspired by Bundelkhand's solar hubs, will meet 30% energy needs, qualifying for additional rebates under the Green Hydrogen Policy's renewable provisions. The facility will adhere to ISO 13485 and CE standards, ensuring eco-friendly materials like biodegradable polymers for disposables. This not only minimizes environmental impact but also positions Ajesha for global markets demanding sustainable sourcing.

The manufacturing setup will feature state-of-the-art cleanrooms (Class 100,000), automated injection molding machines, and ethylene oxide sterilization units. Production capacity: 10 million syringes annually, 5 million IV sets, and 2 million surgical kits. Quality control labs with HPLC and microbial testing will ensure compliance with FDA and EU norms. By localizing production, Ajesha aims to cut costs by 20-30%, making disposables affordable for India's public health system, including Ayushman Bharat schemes.

Challenges exist: Obra's remote location demands robust supply chains for raw materials like polypropylene and latex, sourced from Gujarat or abroad. However, UP's incentives mitigate this—freight subsidies and GST reimbursements for 10 years. The PLI scheme for medical devices, with ₹871 crore allocated for parks in Greater Noida, provides a blueprint; Ajesha could integrate with these ecosystems for R&D collaborations.

Looking ahead, Ajesha's project could catalyze more greenfield initiatives in Obra. UP's Bulk Drug Parks scheme, offering ₹100 crore grants for infrastructure, extends to medical devices, potentially attracting clusters. With incentives like 100% electricity duty exemption for 10 years and employee cost reimbursements, the region could evolve into a healthcare manufacturing belt, rivaling Noida's SPM Medicare or Kanpur's Aditya Dispomed.

In conclusion, Ajesha Chemicals' greenfield project in Obra exemplifies how targeted incentives can drive industrial transformation. By focusing on medical and surgical disposables, it addresses health security, generates employment, and promotes green practices. As Uttar Pradesh eyes a $1 trillion economy by 2027, such ventures in Obra signal a bright, sustainable future for Purvanchal.